Richard L Gallo

USPTO Granted Patents = 17 (Patent Applications = 15)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 51(Granted Patents)

Company Filing History:

17 out of 15,488

University of California

patents

1 out of 41

National Jewish Medical and Research Center

patents

1 out of 896

The United States Government As Represented by the Department of Veterans Affairs

patents

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12427151 - Compositions and method of treating cancer (2025-09-30),

2. 12285404 - Prevention of rosacea inflammation (2025-04-29),

3. 12201655 - Antimicrobial therapy (2025-01-21),

4. 11439659 - Methods and compositions to prevent and treat inflammation and allergic reactions (2022-09-13),

5. 11400098 - Method of treating microbial infections (2022-08-02),

6. 11382890 - Prevention of rosacea inflammation (2022-07-12),

7. 11260058 - Compositions and method of treating cancer (2022-03-01),

8. 10980848 - Antimicrobial therapy (2021-04-20),

9. 10085997 - Method of treating microbial infections (2018-10-02),

10. 9801848 - Prevention of rosacea inflammation (2017-10-31),

11. 9340769 - [object Object] (2016-05-17),

12. 9303258 - Method and compositions comprising small RNA agonist and antagonists to modulate inflammation (2016-04-05),

13. 7777000 - Anti-viral activity of cathelicidin peptides (2010-08-17),

14. 7776823 - Human cathelicidin antimicrobial peptides (2010-08-17),

15. 7718618 - Human cathelicidin antimicrobial peptides (2010-05-18),

Title: The Innovative Contributions of Richard L. Gallo

Introduction

Richard L. Gallo is a prominent inventor based in San Diego, California, known for his significant contributions to the field of dermatology and cancer treatment. With a total of 17 patents to his name, Gallo has made remarkable strides in developing methods and compositions that address critical health issues, particularly those related to skin damage and inflammatory conditions.

Latest Patents

Among his latest patents, Gallo has developed compositions and methods for treating cancer, specifically focusing on preventing skin damage due to UV radiation. This innovative method involves contacting the skin with an effective amount of a composition containing specific compounds aimed at mitigating the harmful effects of UV exposure. Additionally, he has contributed to the prevention of rosacea inflammation, demonstrating the role of mast cell stabilizers in treating this condition. His research highlights the involvement of mast cells, cathelicidin, serine protease, and vitamin D3 in rosacea pathology, as well as the potential use of antagonists and inhibitors to treat the disorder.

Career Highlights

Gallo's career has been marked by his association with esteemed institutions such as the University of California and the National Jewish Medical and Research Center. His work in these organizations has allowed him to explore and develop groundbreaking treatments that have the potential to improve the quality of life for many individuals suffering from skin-related ailments.

Collaborations

Throughout his career, Gallo has collaborated with notable colleagues, including Teruaki Nakatsuji and Anna Di Nardo. These partnerships have fostered a collaborative environment that has been instrumental in advancing research and innovation in dermatological treatments.

Conclusion

Richard L. Gallo's contributions to the field of dermatology and cancer treatment through his innovative patents and collaborations underscore his commitment to improving health outcomes. His work continues to inspire advancements in medical research and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.